Nanjing Vishee Medical Technology Co., Ltd (SHA:688580)
46.37
+0.08 (0.17%)
Jun 3, 2025, 3:00 PM CST
SHA:688580 Revenue
Nanjing Vishee Medical Technology had revenue of 95.91M CNY in the quarter ending March 31, 2025, with 9.40% growth. This brings the company's revenue in the last twelve months to 408.30M, down -10.14% year-over-year. In the year 2024, Nanjing Vishee Medical Technology had annual revenue of 400.06M, down -13.45%.
Revenue (ttm)
408.30M
Revenue Growth
-10.14%
P/S Ratio
10.87
Revenue / Employee
638.97K
Employees
639
Market Cap
4.44B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 400.06M | -62.16M | -13.45% |
Dec 31, 2023 | 462.22M | 140.60M | 43.72% |
Dec 31, 2022 | 321.62M | -108.42M | -25.21% |
Dec 31, 2021 | 430.04M | 51.68M | 13.66% |
Dec 31, 2020 | 378.37M | 59.49M | 18.66% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Sichuan Biokin Pharmaceutical | 5.82B |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |